Kern JK - Search Results

1

The biological basis of autism spectrum disorders: Understanding causation and treatment by clinical geneticists.

Geier DA, Kern JK, Geier MR. Geier DA, et al. Among authors: kern jk. Acta Neurobiol Exp (Wars). 2010;70(2):209-26. Acta Neurobiol Exp (Wars). 2010. PMID: 20628444

2

A prospective study of transsulfuration biomarkers in autistic disorders.

Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR. Geier DA, et al. Among authors: kern jk. Neurochem Res. 2009 Feb;34(2):386-93. doi: 10.1007/s11064-008-9782-x. Epub 2008 Jul 9. Neurochem Res. 2009. PMID: 18612812

3

Biomarkers of environmental toxicity and susceptibility in autism.

Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, Geier MR. Geier DA, et al. Among authors: kern jk. J Neurol Sci. 2009 May 15;280(1-2):101-8. doi: 10.1016/j.jns.2008.08.021. Epub 2008 Sep 25. J Neurol Sci. 2009. PMID: 18817931

4

A prospective study of prenatal mercury exposure from maternal dental amalgams and autism severity.

Geier DA, Kern JK, Geier MR. Geier DA, et al. Among authors: kern jk. Acta Neurobiol Exp (Wars). 2009;69(2):189-97. Acta Neurobiol Exp (Wars). 2009. PMID: 19593333

5

A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disorders.

Geier DA, Kern JK, Geier MR. Geier DA, et al. Among authors: kern jk. J Toxicol Environ Health A. 2009;72(24):1585-91. doi: 10.1080/15287390903232475. J Toxicol Environ Health A. 2009. PMID: 20077233

6

Blood mercury levels in autism spectrum disorder: Is there a threshold level?

Geier DA, Audhya T, Kern JK, Geier MR. Geier DA, et al. Among authors: kern jk. Acta Neurobiol Exp (Wars). 2010;70(2):177-86. Acta Neurobiol Exp (Wars). 2010. PMID: 20628441

7

A significant relationship between mercury exposure from dental amalgams and urinary porphyrins: a further assessment of the Casa Pia children's dental amalgam trial.

Geier DA, Carmody T, Kern JK, King PG, Geier MR. Geier DA, et al. Among authors: kern jk. Biometals. 2011 Apr;24(2):215-24. doi: 10.1007/s10534-010-9387-0. Epub 2010 Nov 5. Biometals. 2011. PMID: 21053054 Clinical Trial.

8

A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders.

Geier DA, Kern JK, Davis G, King PG, Adams JB, Young JL, Geier MR. Geier DA, et al. Among authors: kern jk. Med Sci Monit. 2011 Jun;17(6):PI15-23. doi: 10.12659/msm.881792. Med Sci Monit. 2011. PMID: 21629200 Free PMC article. Clinical Trial.

9

A dose-dependent relationship between mercury exposure from dental amalgams and urinary mercury levels: a further assessment of the Casa Pia Children's Dental Amalgam Trial.

Geier DA, Carmody T, Kern JK, King PG, Geier MR. Geier DA, et al. Among authors: kern jk. Hum Exp Toxicol. 2012 Jan;31(1):11-7. doi: 10.1177/0960327111417264. Epub 2011 Jul 29. Hum Exp Toxicol. 2012. PMID: 21803780 Clinical Trial.

10

An evaluation of the role and treatment of elevated male hormones in autism spectrum disorders.

Geier DA, Kern JK, King PG, Sykes LK, Geier MR. Geier DA, et al. Among authors: kern jk. Acta Neurobiol Exp (Wars). 2012;72(1):1-17. Acta Neurobiol Exp (Wars). 2012. PMID: 22508080 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results